Drugs / ReT01 ACT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06257680 | Apr 2024 → Feb 2025 overdue | neoplasm | Aeonvital Biomedicine | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ReT01 ACT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06257680 ↗ |